Overview

Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This study examines whether low intensity, dose adjusted warfarin prolongs the time to mechanical failure of hemodialysis catheters without resulting in an unacceptable rate of bleeding.
Phase:
Phase 3
Details
Lead Sponsor:
Hamilton Health Sciences Corporation
Treatments:
Warfarin